{"id":"carindacillin","rwe":[],"tags":[{"label":"Penicillin-class Antibacterial","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"J01CA05","category":"atc"},{"label":"Active","category":"status"},{"label":"Bacterial urinary infection","category":"indication"},{"label":"Pfizer","category":"company"},{"label":"Approved 1970s","category":"decade"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=carindacillin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:52:20.658848+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T00:52:40.664027+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:52:25.869325+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=carindacillin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:52:26.347202+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1596/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:52:27.055174+00:00"}},"allNames":"cardinacillin","offLabel":[],"synonyms":["carindacillin","carbenicillin indanyl","carbenicillin indanyl ester","cardinacillin","indanyl carbenicillin","carbenicillin indanyl sodium","carindacillin sodium","CP-15464-2"],"timeline":[{"date":"1972-10-26","type":"positive","source":"DrugCentral","milestone":"FDA approval (Pfizer)"}],"aiSummary":"Carindacillin, marketed by Pfizer, is a bacterial urinary infection treatment currently generating revenue in the market with a key composition patent expiring in 2028. Its mechanism of action, inhibiting bacterial transpeptidase, provides a targeted approach to disrupting bacterial cell wall synthesis, distinguishing it within the same class of antibiotics such as ampicillin and amoxicillin. The primary risk to Carindacillin's market position is the presence of multiple off-patent competitors, including ampicillin and azlocillin, which may limit its market share and pricing power.","brandName":"Cardinacillin","ecosystem":[{"indication":"Bacterial urinary infection","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"avibactam","slug":"avibactam","company":"Cerexa Inc"}],"globalPrevalence":null}],"mechanism":{"novelty":"Follow-on","modality":"Small Molecule","drugClass":"Penicillin-class Antibacterial","explanation":"","oneSentence":"","technicalDetail":"Cardicillin inhibits the action of transpeptidase, a penicillin-binding protein, which is necessary for the cross-linking of peptidoglycan in the bacterial cell wall, ultimately leading to cell lysis and death."},"commercial":{"launchDate":"1972","_launchSource":"DrugCentral (FDA 1972-10-26, PFIZER)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/508","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=carindacillin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=carindacillin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:15:04.074619","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:52:40.664104+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ampicillin","drugSlug":"ampicillin","fdaApproval":"1965-12-17","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"carbenicillin","drugSlug":"carbenicillin","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"amoxicillin","drugSlug":"amoxicillin","fdaApproval":"1974-12-09","patentExpiry":"May 7, 2027","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"bacampicillin","drugSlug":"bacampicillin","fdaApproval":"1980-12-22","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"azlocillin","drugSlug":"azlocillin","fdaApproval":"1982-09-03","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mezlocillin","drugSlug":"mezlocillin","fdaApproval":"1981-09-21","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"mecillinam","drugSlug":"mecillinam","fdaApproval":"","relationship":"same-class"},{"drugName":"piperacillin","drugSlug":"piperacillin","fdaApproval":"1981-12-29","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ticarcillin","drugSlug":"ticarcillin","fdaApproval":"1976-11-09","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"hetacillin","drugSlug":"hetacillin","fdaApproval":"","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"carindacillin","indications":{"approved":[{"name":"Bacterial urinary infection","source":"DrugCentral","snomedId":312124009,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ampicillin","brandName":"ampicillin","genericName":"ampicillin","approvalYear":"1965","relationship":"same-class"},{"drugId":"carbenicillin","brandName":"carbenicillin","genericName":"carbenicillin","approvalYear":"","relationship":"same-class"},{"drugId":"amoxicillin","brandName":"amoxicillin","genericName":"amoxicillin","approvalYear":"1974","relationship":"same-class"},{"drugId":"bacampicillin","brandName":"bacampicillin","genericName":"bacampicillin","approvalYear":"1980","relationship":"same-class"},{"drugId":"azlocillin","brandName":"azlocillin","genericName":"azlocillin","approvalYear":"1982","relationship":"same-class"},{"drugId":"mezlocillin","brandName":"mezlocillin","genericName":"mezlocillin","approvalYear":"1981","relationship":"same-class"},{"drugId":"mecillinam","brandName":"mecillinam","genericName":"mecillinam","approvalYear":"","relationship":"same-class"},{"drugId":"piperacillin","brandName":"piperacillin","genericName":"piperacillin","approvalYear":"1981","relationship":"same-class"},{"drugId":"ticarcillin","brandName":"ticarcillin","genericName":"ticarcillin","approvalYear":"1976","relationship":"same-class"},{"drugId":"hetacillin","brandName":"hetacillin","genericName":"hetacillin","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000146734","MMSL":"4352","NDDF":"002700","UNII":"5V278481KE","VUID":"4018408","CHEBI":"CHEBI:52015","VANDF":"4018408","INN_ID":"3405","RXNORM":"2015","UMLSCUI":"C0054667","chemblId":"CHEMBL1596","ChEMBL_ID":"CHEMBL1596","KEGG_DRUG":"D01283","DRUGBANK_ID":"DB09319","PDB_CHEM_ID":" 0JM","PUBCHEM_CID":"93184","SNOMEDCT_US":"34731007","IUPHAR_LIGAND_ID":"12276","SECONDARY_CAS_RN":"26605-69-6","MESH_DESCRIPTOR_UI":"D002228","MESH_SUPPLEMENTAL_RECORD_UI":"C100244"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1972-","companyName":"Pfizer","relationship":"Original Developer"}],"publicationCount":13,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"J01CA05","allCodes":["J01CA05"]},"biosimilarFilings":[],"originalDeveloper":"Pfizer","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Small Molecule","firstApprovalDate":"1972","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T00:52:40.664104+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}